In patient-derived UOK262 renal carcinoma cells with mutations in the fumarase/fumarate hydratase (FH) gene or cells with a mutation in an OXPHOS complex I subunit, a reductive, glutamine-dependent pathway is the primary metabolic pathway. The gene discussed is FH; the disease is renal carcinoma.